CJC-1295 No Dac (10mg)
Original price was: $87.00.$78.00Current price is: $78.00.
Contents: Lyophilized Powder in 3ml vial
Requires reconstitution with bacteriostatic water
Rigorous Third-Party Testing
Every batch of our research chemicals and peptides undergoes third-party testing.
- Description
- 3rd Party Lab Testing
Description
CJC-1295 No DAC (10mg)
CJC-1295 No DAC (also referenced in technical literature as a modified GHRH 1-29 analog) is a synthetic peptide consisting of a 29-amino-acid chain designed for controlled in vitro signaling and receptor interaction studies. The “No DAC” variant lacks a Drug Affinity Complex extension, resulting in a peptide with a shorter experimental presence compared to DAC-modified analogs. :contentReference[oaicite:1]{index=1}
Product Specifications
| Sequence | Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂ (29 amino acids) :contentReference[oaicite:2]{index=2} |
| Molecular Formula | C₁₅₂H₂₅₂N₄₄O₄₂ :contentReference[oaicite:3]{index=3} |
| Molecular Weight | ~3367.88 g/mol :contentReference[oaicite:4]{index=4} |
| CAS Number | 863288-34-0 :contentReference[oaicite:5]{index=5} |
| Purity | ≥99% (HPLC verified) |
| Form | Lyophilized powder |
| Appearance | White to off-white powder |
Research Applications
- Peptide-receptor interaction studies involving GHRH receptor systems
- Peptide stability and degradation kinetics analysis in buffer and cell culture conditions
- Structure-activity relationship (SAR) investigations comparing analog variants of GHRH peptides
- Receptor binding affinity assays using labeled or competitive ligand approaches
- GPCR-linked signal transduction studies including cAMP accumulation and downstream pathway activation profiling
Quality Documentation
Certificate of Analysis and HPLC chromatogram available for each lot.
For Laboratory Research Use Only
This product is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not for diagnostic, therapeutic, or clinical applications.
